Cancer Research Community Slammed by DNA Pioneer Who Urges Taking More Risks

Share Article

The CBCD agrees with DNA Pioneer Dr. Watson. More risks need to be taken in cancer research.

‘People doing cancer research don’t try to know everything, they don’t seem to be willing to take chances.” - Dr. James Watson

The Center for the Biology of Chronic Disease (CBCD) has learned that DNA pioneer and Nobel Prize winner, James Watson recently published a scathing article against America’s cancer research establishment. His paper was published in the journal, Open Biology and in it, he argued that the $100 million U.S. project to determine the DNA changes that drive nine forms of cancer are: "not likely to produce the truly breakthrough drugs that we now so desperately need."

The British Mail Online published an article by Fiona Macrae [1] in which she reported that Dr. Watson made a speech on the topic at the Euroscience Open Forum in Dublin where he said, “I think we should focus on why we can’t cure it,” (speaking of cancer), ‘I think if we know why we are not able to cure it and if we can write down on paper ways by which we might overcome these things, then we have a chance.”

‘People doing cancer research don’t try to know everything, they don’t seem to be willing to take chances.”

The CBCD is in full agreement with Dr. Watson’s remarks. In fact, for years the CBCD has advocated new and innovative approaches toward finding cures for various chronic diseases, including cancer.

In an article on Dr. Watson’s comments published by Reuters, author Sharon Begley [2] quoted molecular biologist Mark Ptashne of Memorial Sloan-Kettering Cancer Center in New York who said that, “The great hope of the modern targeted approach was that with DNA sequencing we would be able to find what specific genes, when mutated, caused each cancer.”

Research by Dr. Hanan Polansky published by the CBCD provides a theory on the origin of chronic disease, including cancer.

Albert Einstein said, “A theory is more impressive the greater the simplicity of its premises, the more different kinds of things it relates, and the more extended its area of applicability” (Einstein 1951, ibid, p. 33).

Dr. Polanksy’s theory is based on one basic premise: microcompetition with foreign DNA causes chronic disease.

The derived conclusions (the subsequent events in the different sequences of quantitative events) relate numerous seemingly unrelated observations reported in studies with animals, humans, in vitro, in vivo, on a molecular level, cellular level, clinical level, on cancer, atherosclerosis, obesity, osteoarthritis, type II diabetes, alopecia, type I diabetes, multiple sclerosis, asthma, lupus, thyroiditis, inflammatory bowel disease, rheumatoid arthritis, psoriasis, atopic dermatitis, graft versus host disease, and other chronic diseases.

The CBCD believes that in light of Dr. Watson’s new, published paper, in light of the U.S.’s annual cancer report that was just recently published, and in light of Einstein’s statement which said, “The truly great advances in our understanding of nature originated in a way almost diametrically opposed to induction. The intuitive grasp of the essentials of a large complex of facts leads the scientist to the postulation of a hypothetical basic law, or several laws. From these laws, he derives his conclusions, …which can then be compared to experience. Basic laws (or axioms) and conclusions together form what is called a “theory.” Every expert knows that the greatest advances in natural science … originated in this manner.”…Dr. Polanksy’s theory on Microcompetition with foreign DNA and the cause of chronic disease should be investigated in depth.

This is especially true when it comes to cancer.

Consider breast cancer as an example. The current belief in the medical community holds that most cases of breast cancer are caused by a mutation in a certain gene. Genes, in general, produce proteins, which are the building blocks of cells. The concentration of proteins is tightly regulated. A mutated or injured gene produces an abnormal concentration of its protein, which may lead to disease.

In 1994, Mark Skolnick, PhD, discovered the BRCA1 gene (BRCA1 is short for BReast CAncer 1). Following the discovery, scientists observed a low level of the BRCA1 protein in breast cancer tissues.

This study created a lot of excitement. At the time, scientists believed that they were on the verge of finding the cause of breast cancer. The reasoning was that breast cancer patients must have a mutated BRCA1 gene, which would explain the decreased production of the protein, and the development of tumors.

In the United States, 180,000 cases of breast cancer are diagnosed each year. However, only 5% of these cases have a mutated BRCA1 gene. In more than 95% of the breast cancer patients the gene is not mutated.

So here is the mystery. If the gene is not mutated in the great majority of the breast cancer patients, why are the tumors showing a low level of the BRCA1 protein? The BRCA1 gene is not unique. Many normal (perfect shape, non-mutated) genes exhibit an unexplained, abnormal (increased or decreased) production of proteins in cancer.

Breast cancer is only one example!

The most basic explanation, according to Dr. Hanan Polansky highly acclaimed scientific discovery [3], is that the cause of most cancers is latent viral DNA that lays hidden in human cells.

To survive, the latent viral DNA feeds off the resources it "steals" from the human DNA in these cells, thereby creating a supply shortage for the human genes. The latent viral DNA, which is a genetic parasite, in fact "starves" the human genes, and causes them to behave irregularly, which leads to disease. This effect of the foreign DNA on human genes inspired Dr. Hanan Polansky to call the discovery the "starved" gene phenomenon.

The CBCD therefore calls on the scientific community to investigate Dr. Polansky’s theory in full. That theory is detailed in Dr. Polansky’s “Purple Book” which was published by the CBCD and which can be downloaded for free from the CBCD’s website here:

For more information on the Center for the Biology of Chronic Disease, or to schedule an interview with one of our researchers, please visit or call 585-250-9999.




[3] Polansky H. Microcompetition with foreign DNA and the origin of chronic disease. CBCD publishing. 2003. 543 p.


The Center for the Biology of Chronic Disease (CBCD, is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments for these diseases.

We invite biologists, virologists, scientists everywhere to download Dr. Polansky’s book, “Microcompetition with Foreign DNA and the Origin of Chronic Disease” here:

The CBCD published the “Purple” book by Dr. Hanan Polansky.

The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between the DNA of latent (chronic) viruses and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

John Boyd
Center for the Biology of Chronic Disease (CBCD).
(585) 250-9999
Email >
Visit website